EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Trading Down 6.2% - Should You Sell? - Daily Political
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
Novavax (NASDAQ:NVAX) Trading Down 7.3% - Here's Why - Stock Observer
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Zolmax
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX) - Daily Political
Zacks Research Has Positive Outlook for Novavax Q2 Earnings - Stock Observer
Why Novavax (NVAX) Stock Is Trading Up Today
Novavax (NASDAQ:NVAX) Stock Price Up 11.6% - What's Next? - Daily Political
The Bull Case For Novavax (NVAX) Could Change Following Shah Capital's Activist Governance Challenge - Learn Why
Assessing Novavax (NVAX) Valuation As Shah Capital Challenges Leadership And Sanofi Partnership
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know
The Top 5 Analyst Questions From Novavax's Q1 Earnings Call
Are Novavax's (NVAX) Activist Pressure and Partnership Pivot Quietly Rewriting Its Investment Narrative?
Israel to offer non-mRNA coronavirus vaccine
Novavax Inc at Bank of America Global Healthcare Conference Transcript
Novavax (NVAX) Is Up 25.9% After Pfizer Matrix-M Deal And Q1 Beat On Expectations - What's Changed
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
%20destroying%20a%20cancer%20cell%20by%20Alpha%20Tauri%203D%20Graphics%20via%20Shutterstock.jpg)
Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes
Novavax (NVAX) Valuation Check After Pfizer Licensing Deal And Partnership-Led Earnings Beat
